11 Capital Partners LP Invests $6.66 Million in Axon Enterprise, Inc. (NASDAQ:AXON)

11 Capital Partners LP acquired a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) during the 4th quarter, HoldingsChannel.com reports. The fund acquired 11,200 shares of the biotechnology company’s stock, valued at approximately $6,656,000. Axon Enterprise comprises approximately 2.7% of 11 Capital Partners LP’s portfolio, making the stock its 15th largest position.

Several other large investors have also bought and sold shares of the company. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise in the 4th quarter worth approximately $40,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise in the 4th quarter worth approximately $45,000. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise in the 4th quarter worth approximately $53,000. GPS Wealth Strategies Group LLC increased its position in shares of Axon Enterprise by 74.1% during the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock valued at $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Versant Capital Management Inc increased its position in shares of Axon Enterprise by 4,750.0% during the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $602.46 on Tuesday. The firm has a market capitalization of $46.90 billion, a PE ratio of 155.67, a P/E/G ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The business has a 50-day moving average of $545.69 and a two-hundred day moving average of $573.85. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on AXON shares. Needham & Company LLC reissued a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research report on Wednesday, April 23rd. The Goldman Sachs Group lifted their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a “buy” rating in a report on Monday, January 27th. JMP Securities reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Barclays reissued a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. Finally, Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $626.45.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction on Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now owns 1,627 shares of the company’s stock, valued at $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares of the company’s stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 6.10% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.